Literature DB >> 25323770

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.

J Lyth1, H Eriksson, J Hansson, C Ingvar, M Jansson, J Lapins, E Månsson-Brahme, P Naredi, U Stierner, G Ullenhag, J Carstensen, C Lindholm.   

Abstract

BACKGROUND: Both patient survival and the proportion of patients diagnosed with thin cutaneous malignant melanoma (CMM) have been steadily rising in Sweden as in most Western countries, although the rate of improvement in survival appears to have declined in Sweden at the end of the last millennium.
OBJECTIVES: To analyse the most recent trends in the distribution of tumour thickness (T category) as well as CMM-specific survival in Swedish patients diagnosed during 1997-2011.
METHODS: This nationwide population-based study included 30,590 patients registered in the Swedish Melanoma Register (SMR) and diagnosed with a first primary invasive CMM during 1997-2011. The patients were followed through 2012 in the national Cause of Death Register.
RESULTS: Logistic and Cox regression analyses adjusting for age at diagnosis, tumour site and healthcare region were carried out. The odds ratio for being diagnosed with thicker tumours was significantly reduced (P < 0·001) and the CMM-specific survival significantly improved in men diagnosed during 2007-2011 compared with men diagnosed during 1997-2001 (hazard ratio = 0·81; 95% confidence interval 0·72-0·91; P < 0·001), while the corresponding differences for women were not significant. Women were diagnosed with significantly thicker tumours during 2002-2006 and a tendency towards decreased survival was observed compared with those diagnosed earlier (during 1997-2001) and later (during 2007-2011).
CONCLUSIONS: In Sweden, the CMMs of men are detected earlier over time and this seems to be followed by an improved CMM-specific survival for men. Women are still diagnosed with considerably thinner tumours and they experience a better survival than men.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2015        PMID: 25323770     DOI: 10.1111/bjd.13483

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry.

Authors:  Trude Eid Robsahm; Per Helsing; Yngvar Nilssen; Linda Vos; Syed Mohammad H Rizvi; Lars A Akslen; Marit B Veierød
Journal:  Clin Epidemiol       Date:  2018-05-09       Impact factor: 4.790

2.  Types of second primary cancer influence overall survival in cutaneous melanoma.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Kristina Sundquist; Jan Sundquist; Asta Försti; Akseli Hemminki; Kari Hemminki
Journal:  BMC Cancer       Date:  2021-10-19       Impact factor: 4.430

3.  Perception of information to Swedish melanoma patients in routine clinical practice - a cross-sectional survey.

Authors:  Helena Tufvesson Stiller; Rasmus Mikiver; Srinivas Uppugunduri; Marcus Schmitt-Egenolf
Journal:  BMC Cancer       Date:  2022-02-09       Impact factor: 4.430

4.  Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).

Authors:  Veronica Di Carlo; Charles A Stiller; Nora Eisemann; Andrea Bordoni; Melissa Matz; Maria P Curado; Laetitia Daubisse-Marliac; Mikhail Valkov; Jean-Luc Bulliard; David Morrison; Chris Johnson; Fabio Girardi; Rafael Marcos-Gragera; Mario Šekerija; Siri Larønningen; Eunice Sirri; Michel P Coleman; Claudia Allemani
Journal:  Br J Dermatol       Date:  2022-07-28       Impact factor: 11.113

5.  Differences in cutaneous melanoma treatment and patient satisfaction.

Authors:  Jakob D Wikstrom; Lena Lundeberg; Margareta Frohm-Nilsson; Ada Girnita
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

6.  Demographic, Clinical, and Pathologic Features of Patients With Cutaneous Melanoma: Final Analysis of the Brazilian Melanoma Group Database.

Authors:  Alberto Julius Alves Wainstein; João Pedreira Duprat Neto; Mauro Yoshiaki Enokihara; Eduard René Brechtbühl; Felice Riccardi; Gilles Landman; Andreia Cristina de Melo; Vinicius de Lima Vazquez; Rodrigo Ramella Munhoz; Ivan Dunshee De Abranches Oliveira Santos Filho; Eduardo Bertolli; Ana Paula Drummond-Lage; Bianca Costa Soares de Sá; Luciane Botelho; Jose Higino Steck; Francisco Aparecido Belfort; Marcus Maia; Renato Marchiori Bakos; Elimar Elias Gomes; Rafael Schmerling; Flavio Cavarsan
Journal:  JCO Glob Oncol       Date:  2020-04

7.  Second Primary Cancers in Melanoma Patients Critically Shorten Survival.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Kristina Sundquist; Jan Sundquist; Asta Försti; Akseli Hemminki; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2020-01-23       Impact factor: 4.790

8.  Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma: A Single-center Retrospective Analysis.

Authors:  Antonella Vecchiato; Elisa Zonta; Luca Campana; Giacomo Dal Bello; Marco Rastrelli; Carlo Riccardo Rossi; Mauro Alaibac
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.